ORIVA Probio-10 Plus Capsule
ORIVA Probio-10 Plus Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL22066085NC
- Type
- Health supplement
- Published status
- PRODUCT APPROVED
- Licence holder
- BIO-SCIENCE MARKETING SDN. BHD.
- Manufacturer
- GN NEUTRICEUTICALS SDN. BHD.
- Registration period starting
- 2022-06-20
- Published validity end
- 2027-06-20
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| BIFIDOBACTERIUM LONGUM | BIFIDOBACTERIUM LONGUM[50 mg,505.6 mg] | Not identified |
| LACTOBACILLUS ACIDOPHILUS | LACTOBACILLUS ACIDOPHILUS[50 mg,505.6 mg] | Not identified |
| LACTOBACILLUS RHAMNOSUS | LACTOBACILLUS RHAMNOSUS[50 mg,505.6 mg] | Not identified |
| LACTOBACILLUS REUTERI | LACTOBACILLUS REUTERI[50 mg,505.6 mg] | Not identified |
| BIFIDOBACTERIUM LACTIS | BIFIDOBACTERIUM LACTIS[50 mg,505.6 mg] | Not identified |
| BIFIDOBACTERIUM BIFIDUM | BIFIDOBACTERIUM BIFIDUM[20 mg,505.6 mg] | Not identified |
| LACTOBACILLUS BULGARICUS | LACTOBACILLUS BULGARICUS[20 mg,505.6 mg] | Not identified |
| STREPTOCOCCUS THERMOPHILUS | STREPTOCOCCUS THERMOPHILUS[20 mg,505.6 mg] | Not identified |
| LACTOBACILLUS CASEI | LACTOBACILLUS CASEI[20 mg,505.6 mg] | Not identified |
| LACTOBACILLUS SALIVARIUS | LACTOBACILLUS SALIVARIUS[20 mg,505.6 mg] | Not identified |
| INULIN | INULIN[105.6 mg,505.6 mg] | Inuline |
| AMYLASE | AMYLASE[5.9 mg,505.6 mg] | Amylase |
| PROTEASE | PROTEASE[3.1 mg,505.6 mg] | Protéase |
| LACTASE | LACTASE[2.3 mg,505.6 mg] | Lactase |
| LIPASE | LIPASE[0.1 mg,505.6 mg] | Lipase |
| CELLULASE | CELLULASE[1.5 mg,505.6 mg] | Cellulase |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- BIFIDOBACTERIUM LONGUM[50 mg,505.6 mg],LACTOBACILLUS ACIDOPHILUS[50 mg,505.6 mg],LACTOBACILLUS RHAMNOSUS[50 mg,505.6 mg],LACTOBACILLUS REUTERI[50 mg,505.6 mg],BIFIDOBACTERIUM LACTIS[50 mg,505.6 mg],BIFIDOBACTERIUM BIFIDUM[20 mg,505.6 mg],LACTOBACILLUS BULGARICUS[20 mg,505.6 mg],STREPTOCOCCUS THERMOPHILUS[20 mg,505.6 mg],LACTOBACILLUS CASEI[20 mg,505.6 mg],LACTOBACILLUS SALIVARIUS[20 mg,505.6 mg],INULIN[105.6 mg,505.6 mg],AMYLASE[5.9 mg,505.6 mg],PROTEASE[3.1 mg,505.6 mg],LACTASE[2.3 mg,505.6 mg],LIPASE[0.1 mg,505.6 mg],CELLULASE[1.5 mg,505.6 mg]
- Valid until
- 2027-06-20
- Registration date
- 2022-06-20
- Published description
- HEALTH SUPPLEMENT
- Licence holder
- BIO-SCIENCE MARKETING SDN. BHD.
- Producer
- GN NEUTRICEUTICALS SDN. BHD.
- Published name
- ORIVA Probio-10 Plus Capsule
- Published reference
- 202202216956N
- Registration number
- MAL22066085NC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL22066085NC
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.